Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Board changes and trading update

30 Jan 2015 07:00

RNS Number : 5581D
Plant Health Care PLC
30 January 2015
 



30 Jan 2015

 

PLANT HEALTH CARE plc

 

("Plant Health Care" or the "Company")

 

Board changes and trading update

Plant Health Care announces organisation changes and a pre-close trading statement in respect of the year ended 31 December 2014.

Plant Health Care (AIM: PHC), a leading provider of novel patent-protected biological products to the global agriculture markets, is pleased to announce that Dr. Richard Webb, formerly a Non-Executive Director, has become an Executive Director of Plant Health Care plc. Richard will be responsible for supporting the Chief Scientific Officer, Dr. Zhongmin Wei, as the company continues to expand its research and development programme.

Richard will step down from the Audit Committee and be replaced by James Ede-Golightly. In due course, the company intends to appoint an additional independent non-executive director with extensive commercial experience in the sector.

During 2014, the Company continued to make substantial progress in our core research objectives, as evidenced by the launch of the Innatus 3G™ technology platform. Major industry players have responded positively to Innatus 3G and we are in active discussions with them as we pursue potential partnerships. Our intellectual property portfolio continues to strengthen our leading position in protein-based bio-stimulants. Regarding our existing products, we have added material new distribution agreements over recent months, which we anticipate will lead to further sales growth as registrations are obtained outside current markets. We are actively exploring options to extend and accelerate sales further.

Revenue for the year ended 31 December 2014 amounted to $6.9 million, of which $0.15 million was one-off milestone payments. The company's sales of proprietary products (excluding one-off payments) grew 40% over 2013 with combined sales of Harpin and Myconate reaching $3.5 million.

Cash and investments at the year-end were $16.7 million.

More details will be provided in the announcement of the Company's 2014 results, scheduled for 30 March 2015.

- ENDS -

For further information, please contact:

Plant Health Care plc

Paul Schmidt, Chief Executive Officer Tel: +1 (919) 926 1600

 

Liberum Capital - Nomad and Broker

Clayton Bush Tel: +44 (0) 20 3100 2000

 

LHA

Ed McGregor / Jody Burfening Tel: +1 (212) 838 3777

 

Company website: www.planthealthcare.com

 

About Plant Health Care: Plant Health Care is a leading provider of novel patent-protected biological products to the global agriculture markets. Through the commercialisation of these products, Plant Health Care is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. The Company's ordinary shares have been quoted on the AIM market of the London Stock Exchange since July 2004 (ticker symbol: PHC).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEADFNAEESEAF
Date   Source Headline
29th Aug 200810:37 amRNSNotice of Results
15th Aug 200812:36 pmRNSHolding(s) in Company
1st Aug 20081:08 pmRNSTotal Voting Rights
7th Jul 200812:21 pmRNSHolding(s) in Company
4th Jul 20087:00 amRNSProduct Update
3rd Jul 20087:00 amRNSCleantech Index
2nd Jul 200812:07 pmRNSStock Award
1st Jul 200811:49 amRNSTotal Voting Rights
17th Jun 20085:36 pmRNSAdditional Listing
17th Jun 20083:47 pmRNSNotification of Shareholding
13th Jun 20082:07 pmRNSHolding(s) in Company
12th Jun 20087:00 amRNSField Trials
6th Jun 200812:59 pmRNSResult of Annual General Meet
6th Jun 20087:00 amRNSAGM Statement and Trading Upd
3rd Jun 20087:30 amRNSField Trials
2nd Jun 20089:50 amRNSTotal Voting Rights
13th May 200812:41 pmRNSDirectors' dealings and addit
1st May 20082:39 pmRNSAdditional Listing
30th Apr 20086:11 pmRNSAnnual Report and Accounts
30th Apr 200811:24 amRNSTotal Voting Rights
28th Apr 20088:09 amRNSNew Trials
14th Apr 20085:39 pmRNSDirector/PDMR Shareholding
2nd Apr 20086:18 pmRNSDirector/PDMR Shareholding
1st Apr 20087:01 amRNSDirectorate Change
1st Apr 20087:01 amRNSTotal Voting Rights
31st Mar 20087:02 amRNSFinal Results
12th Mar 20084:40 pmRNSAdditional Listing
29th Feb 20084:59 pmRNSTotal Voting Rights
21st Feb 20087:01 amRNSStatement re Monsanto
18th Feb 20088:00 amRNSASA Partnership
12th Feb 20085:14 pmRNSAdditional Listing
31st Jan 20084:03 pmRNSTotal Voting Rights
21st Jan 20087:01 amRNSRe Agreement
21st Jan 20087:01 amRNSProduct Update
21st Jan 20087:01 amRNSTrading Statement
14th Jan 200811:57 amRNSNotification of Shareholding
9th Jan 20089:00 amRNSField Trial Update
31st Dec 200712:51 pmRNSTotal Voting Rights
19th Dec 20079:00 amRNSNotification of Shareholding
3rd Dec 20073:00 pmRNSTotal Voting Rights
20th Nov 20079:15 amRNSAdditional Listing
1st Nov 200712:16 pmRNSTotal Voting Rights
24th Oct 20076:13 pmRNSStock Award
22nd Oct 200710:35 amRNSNotification of Shareholding
5th Oct 20073:56 pmRNSNotification of Shareholding
2nd Oct 20074:46 pmRNSNotification of Shareholding
2nd Oct 200712:59 pmRNSTotal Voting Rights
1st Oct 20075:54 pmRNSNotification of Shareholding
1st Oct 20075:51 pmRNSNotification of Shareholding
1st Oct 20073:22 pmRNSDoc re. Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.